Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Belantamab |
Trade Name | |
Synonyms | GSK2857914|GSK-2857914|GSK 2857914 |
Drug Descriptions |
Belantamab is a monoclonal antibody targeting TNFRSF17 (BCMA), which potentially decreases tumor growth (PMID: 34253590). |
DrugClasses | TNFRSF17 Antibody 20 |
CAS Registry Number | 2061894-48-0 |
NCIT ID | C171828 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Belantamab | Belantamab | 0 | 1 |
Belantamab + belantamab mafodotin-blmf + Dexamethasone + Lenalidomide | Belantamab Dexamethasone Lenalidomide belantamab mafodotin-blmf | 0 | 1 |